LCM
IMGN

Lynwood Capital Management’s Immunogen Inc IMGN Stock Holding History

Lynwood Capital Management’s Portfolio IMGN Stock Details IMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-10,000
Closed -$189K – 128
2023
Q2 		$189K Buy
+10,000
New +$118K 0.24% 70

Other funds holding IMGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Lynwood Capital Management's IMGN Position: Q3 2023 in Review

Lynwood Capital Management sold out of Immunogen Inc (IMGN) in Q3 2023, closing a stake of 10,000 shares — an estimated $189K sold.

Lynwood Capital Management first reported a position in IMGN in Q2 2023 and held it in 1 quarter. The position peaked at $189K in Q2 2023. 275 funds tracked by Wall St. Rank hold IMGN as of Q3 2023.

  • Lynwood Capital Management reported no remaining Immunogen Inc position as of Q3 2023 after selling out during the quarter.
  • Lynwood Capital Management sold 10,000 Immunogen Inc shares in Q3 2023, an estimated $189K.
  • Lynwood Capital Management first reported a position in Immunogen Inc in Q2 2023 and held it in 1 quarter.
  • Lynwood Capital Management's Immunogen Inc position peaked at $189K in Q2 2023.
  • 275 funds tracked by Wall St. Rank held Immunogen Inc as of Q3 2023.

Based on Lynwood Capital Management's 13F filing for Q3 2023, filed 1 Nov 2023.